Med24
diabetes 21. 9. 2026 • 2 min read • U.S. Food and Drug Administration (OpenFDA)

Varenicline Varenicline Varenicline Tartrate Varenicline Mic: FDA Clinical Pharmacology, Indications and Prescribing Update

1 INDICATIONS AND USAGE Varenicline tablets are indicated for use as an aid to smoking cessation treatment. Varenicline tablets are a nicotinic receptor partial agonist indicated for use as an aid to smoking cessation treatment. ( 1 and 2.1 )

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Varenicline tablets are indicated as an aid to smoking cessation. The drug functions as a nicotinic receptor partial agonist, binding with high selectivity to α4β2 neuronal nicotinic acetylcholine receptors. This action is believed to reduce reinforcement and reward associated with smoking by blocking nicotine’s effects on the central nervous system’s mesolimbic dopamine system. Varenicline exhibits approximately 90% systemic availability and has a 24-hour elimination half-life.

Sponsored content

Clinical Trial Results

Six clinical trials involving 3659 chronic cigarette smokers demonstrated a 65% completion rate with 12-week treatment followed by 40-week follow-up. Patients typically set a target quit date and begin treatment one week prior. Dosage begins with 0.5 mg once daily for days 1-3, escalating to 0.5 mg twice daily for days 4-7, and then continuing with 1 mg twice daily for 12 weeks. A further 12 weeks of treatment is recommended for successful quitters. Severe renal impairment necessitates a reduced starting dose. Patients unable to tolerate adverse effects may require dose reduction. Treatment involves providing patients with an educational booklet and up to 10 minutes of smoking cessation counseling at weekly visits. The studies enrolled patients with various cardiovascular conditions, COPD, major depressive disorder, and those with previous unsuccessful varenicline attempts, alongside those employing gradual cessation strategies.

Original Scientific Source
U.S. Food and Drug Administration (OpenFDA)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement